Evidence map›Paper›PMID 37293130›Full record

ArticleFrontiers in cell and developmental biology2023

Reversal of memory and autism-related phenotypes in

Kleanthi Chalkiadaki, Elpida Statoulla, Maria Zafeiri, Nabila Haji, Jean-Claude Lacaille, Craig M Powell, Seyed Mehdi Jafarnejad, Arkady Khoutorsky, Christos G Gkogkas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Kleanthi ChalkiadakiBiomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina, Greece.
Elpida StatoullaBiomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina, Greece.
Maria ZafeiriBiomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina, Greece.
Nabila HajiDepartment of Neurosciences, Center for Interdisciplinary Research on Brain and Learning (CIRCA), Research Group on Neural Signaling and Circuitry (GRSNC), Université de Montréal, Montreal, QC, Canada.
Jean-Claude LacailleDepartment of Neurosciences, Center for Interdisciplinary Research on Brain and Learning (CIRCA), Research Group on Neural Signaling and Circuitry (GRSNC), Université de Montréal, Montreal, QC, Canada.
Craig M PowellDepartment of Neurobiology, Civitan International Research Center at UAB Heersink School of Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, United States.
Seyed Mehdi JafarnejadPatrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Arkady KhoutorskyDepartment of Anesthesia, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Christos G GkogkasBiomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina, Greece.
Foundation for Research and Technology Hellas · GRCanadian Sleep & Circadian Network · CAMcGill University · CAQueen's University Belfast · GBUniversité de Montréal · CAUniversity of Alabama at Birmingham · USUniversity of Edinburgh · GB

Funding

Molecular and Cellular Basis of Neurodevelopmental DisordersR01MH113948 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI POWELL, CRAIG M · 2020 to 2024
$3.3M
Neuroligin Function in vivo: Implications for Autism and Mental RetardationR01MH081164 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI POWELL, CRAIG M · 2009 to 2013
$1.9M
NIMH NIH HHS R01 MH081164NIMH NIH HHS R01 MH113948
6 · The paper itself

Abstract

Tuberous sclerosis complex (TSC) is a rare monogenic disorder co-diagnosed with high rates of autism and is caused by loss of function mutations in the TSC1 or TSC2 genes. A key pathway hyperactivated in TSC is the mammalian/mechanistic target of rapamycin complex 1 (mTORC1), which regulates cap-dependent mRNA translation. We previously demonstrated that exaggerated cap-dependent translation leads to autism-related phenotypes and increased mRNA translation and protein expression of Neuroligin 1 (Nlgn1) in mice. Inhibition of Nlgn1 expression reversed social behavior deficits in mice with increased cap-dependent translation. Herein, we report elevated translation of

Indexed as

autismmemorymTORtranslational controltuberous sclerosis

Identifiers

PMID37293130
PMCPMC10244498
OpenAlexW4378072471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.